96
Views
128
CrossRef citations to date
0
Altmetric
Article

Integration of Regulatory Networks by NKX3-1 Promotes Androgen-Dependent Prostate Cancer Survival

, , , , &
Pages 399-414 | Received 18 Jul 2011, Accepted 04 Nov 2011, Published online: 20 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Joseph F. Cardiello, Gilson J. Sanchez, Mary A. Allen & Robin D. Dowell. (2020) Lessons from eRNAs: understanding transcriptional regulation through the lens of nascent RNAs. Transcription 11:1, pages 3-18.
Read now
Alicia M. Blessing, Kimal Rajapakshe, Lakshmi Reddy Bollu, Yan Shi, Mark A. White, Alexander H. Pham, Chenchu Lin, Philip Jonsson, Constanza J. Cortes, Edwin Cheung, Albert R. La Spada, Robert C. Bast$suffix/text()$suffix/text(), Fatima A. Merchant, Cristian Coarfa & Daniel E. Frigo. (2017) Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression. Autophagy 13:3, pages 506-521.
Read now

Articles from other publishers (126)

Özgür Doğuş Erol, Şimal Şenocak & Fatima Aerts-Kaya. (2023) The Role of Rab GTPases in the development of genetic and malignant diseases. Molecular and Cellular Biochemistry.
Crossref
Nishat Manzar, Promit Ganguly, Umar Khalid Khan & Bushra Ateeq. (2023) Transcription networks rewire gene repertoire to coordinate cellular reprograming in prostate cancer. Seminars in Cancer Biology 89, pages 76-91.
Crossref
Hui-Yu Dong, Lei Ding, Tian-Ren Zhou, Tao Yan, Jie Li & Chao Liang. (2023) FOXA1 in prostate cancer. Asian Journal of Andrology 25:3, pages 287.
Crossref
Ryouichi Tsunedomi, Kiyoshi Yoshimura, Yuta Kimura, Mitsuo Nishiyama, Nobuyuki Fujiwara, Satoshi Matsukuma, Shinsuke Kanekiyo, Hiroto Matsui, Yoshitaro Shindo, Yusaku Watanabe, Yukio Tokumitsu, Shin Yoshida, Michihisa Iida, Nobuaki Suzuki, Shigeru Takeda, Tatsuya Ioka, Shoichi Hazama & Hiroaki Nagano. (2022) Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cells. BMC Cancer 22:1.
Crossref
Jingsong Yu, Haipeng Qi, Zheng Wang, Ze Zhang, Erlin Song, Wenting Song & Ruihua An. (2022) RAB3D, upregulated by aryl hydrocarbon receptor (AhR), promotes the progression of prostate cancer by activating the PI3K/AKT signaling pathway. Cell Biology International 46:12, pages 2246-2256.
Crossref
Jinyong Huang, Meijun Du, Alex Soupir, Liewei Wang, Winston Tan, Krishna R. Kalari, Deepak Kilari, Jong Park, Chiang-Ching Huang, Manish Kohli & Liang Wang. (2022) Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate Cancer. Cancers 14:19, pages 4714.
Crossref
Mi Chen, Shreyas Lingadahalli, Nitin Narwade, Kate Man Kei Lei, Shanshan Liu, Zuxianglan Zhao, Yimin Zheng, Qian Lu, Alexander Hin Ning Tang, Terence Chuen Wai Poon & Edwin Cheung. (2022) TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2‐mediated degradation . EMBO reports 23:8.
Crossref
Yibing Ji, Rahul Kumar, Abhiram Gokhale, Hseu-Ping Chao, Kiera Rycaj, Xin Chen, Qiuhui Li & Dean G. Tang. (2022) LRIG1, a regulator of stem cell quiescence and a pleiotropic feedback tumor suppressor. Seminars in Cancer Biology 82, pages 120-133.
Crossref
Shangzhi Feng, Kecheng Lou, Xiaofeng Zou, Junrong Zou & Guoxi Zhang. (2022) The Potential Role of Exosomal Proteins in Prostate Cancer. Frontiers in Oncology 12.
Crossref
Jon Griffin, Yuqing Chen, James W F Catto & Sherif El-Khamisy. (2022) Gene of the month: NKX3.1. Journal of Clinical Pathology 75:6, pages 361-364.
Crossref
Changjian Li, Xiaoming Zou, Qingxin Cai, Jiacheng Li, Shifeng Yang, Ange Zhang, Chongyan Chen & Lei Zhu. (2022) Comprehensive Expression Profile Analysis of Neutrophil Extracellular Trap-Affected Genes in Gastric Cancer Cells and the Clinical Significance of lncRNA NEAT1-Related Signaling. Frontiers in Oncology 12.
Crossref
Fabrizio Fontana, Martina Anselmi & Patrizia Limonta. (2022) Molecular mechanisms and genetic alterations in prostate cancer: From diagnosis to targeted therapy. Cancer Letters 534, pages 215619.
Crossref
Svetlana K. Vorontsova, Igor V. Zavarzin, Valerii Z. Shirinian, Eugene I. Bozhenko, Olga E. Andreeva, Danila V. Sorokin, Alexander M. Scherbakov & Mikhail E. Minyaev. (2022) Synthesis and crystal structures of D -annulated pentacyclic steroids: looking within and beyond AR signalling in prostate cancer . CrystEngComm 24:11, pages 2089-2099.
Crossref
Doğancan Özturan, Tunç Morova & Nathan A. Lack. (2022) Androgen Receptor-Mediated Transcription in Prostate Cancer. Cells 11:5, pages 898.
Crossref
Changwei Lin, Yifei Chen, Fan Zhang, Baiying Liu, Canbin Xie & Yexun Song. (2022) Encoding gene RAB3B exists in linear chromosomal and circular extrachromosomal DNA and contributes to cisplatin resistance of hypopharyngeal squamous cell carcinoma via inducing autophagy. Cell Death & Disease 13:2.
Crossref
Madeline Farmer, Kristina Redd, Tinsley Roberson, Metta Smith & Kayla Lewis Steed. 2022. Unraveling the Complexities of Metastasis. Unraveling the Complexities of Metastasis 277 300 .
Chia-Lin Chen, Ching-Yu Lin & Hsing-Jien Kung. (2021) Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers. International Journal of Molecular Sciences 22:24, pages 13435.
Crossref
Ji Won Kim, Miso Park, Suntae Kim, Sung Chul Lim, Hyung Shik Kim & Keon Wook Kang. (2021) Anti-metastatic effect of GV1001 on prostate cancer cells; roles of GnRHR-mediated Gαs-cAMP pathway and AR-YAP1 axis. Cell & Bioscience 11:1.
Crossref
Patrick McCoy, Stefano Mangiola, Geoff Macintyre, Ryan Hutchinson, Ben Tran, Bernard Pope, Peter Georgeson, Matthew K. H. Hong, Natalie Kurganovs, Sebastian Lunke, Michael J. Clarkson, Marek Cmero, Michael Kerger, Ryan Stuchbery, Ken Chow, Izhak Haviv, Andrew Ryan, Anthony J. Costello, Niall M. Corcoran & Christopher M. Hovens. (2021) MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer. Prostate Cancer and Prostatic Diseases 24:4, pages 1167-1180.
Crossref
Lingling Hu, Xin Chen, Nitin Narwade, Michelle Gek Liang Lim, Zikai Chen, Chandana Tennakoon, Peiyong Guan, Un In Chan, Zuxianglan Zhao, Mokan Deng, Xiaoling Xu, Wing-Kin Sung & Edwin Cheung. (2021) Single-cell analysis reveals androgen receptor regulates the ER-to-Golgi trafficking pathway with CREB3L2 to drive prostate cancer progression. Oncogene 40:47, pages 6479-6493.
Crossref
Jelena R. Roganović. (2021) microRNA‐146a and ‐155, upregulated by periodontitis and type 2 diabetes in oral fluids, are predicted to regulate SARS‐CoV‐2 oral receptor genes. Journal of Periodontology 92:7.
Crossref
Iván Flores-Ramírez, Miguel Ángel Rivas-Torres, Mauricio Rodríguez-Dorantes, Rubén Gutiérrez-Sagal, Noemi Baranda-Avila & Elizabeth Langley. (2021) Oncogenic role of PinX1 in prostate cancer cells through androgen receptor dependent and independent mechanisms. The Journal of Steroid Biochemistry and Molecular Biology 210, pages 105858.
Crossref
Qiang Peng, Christine Yim-Ping Wong, Isabella Wai-yin Cheuk, Jeremy Yuen-Chun Teoh, Peter Ka-Fung Chiu & Chi-Fai Ng. (2021) The Emerging Clinical Role of Spermine in Prostate Cancer. International Journal of Molecular Sciences 22:9, pages 4382.
Crossref
Qili Luo, Yueping Liu, Zilin Yuan, Lvshuai Huang & Bo Diao. (2021) Expression of Rab3b in Human Glioma: Influence on Cell Proliferation and Apoptosis. Current Pharmaceutical Design 27:7, pages 989-995.
Crossref
Hang Hu, Huan Zhou & Defeng Xu. (2021) A review of the effects and molecular mechanisms of dimethylcurcumin (ASC‐J9) on androgen receptor‐related diseases. Chemical Biology & Drug Design 97:4, pages 821-835.
Crossref
Dhanushka Hewa Bostanthirige, Shravan K. Komaragiri, Jugal B. Joshi, Majid Alzahrani, Isha Saini, Sanjay Jain, Nathan J. Bowen, Matthew C. Havrda & Jaideep Chaudhary. (2021) The helix-loop-helix transcriptional regulator Id4 is required for terminal differentiation of luminal epithelial cells in the prostate. Oncoscience 8, pages 14-30.
Crossref
Ainsley Mike Antao, Suresh Ramakrishna & Kye-Seong Kim. (2021) The Role of Nkx3.1 in Cancers and Stemness. International Journal of Stem Cells.
Crossref
Chunjiang Yu, Xin Qi, Yuxin Lin, Yin Li & Bairong Shen. (2020) iODA: An integrated tool for analysis of cancer pathway consistency from heterogeneous multi-omics data. Journal of Biomedical Informatics 112, pages 103605.
Crossref
Zhuo Zeng, Daxing Xie & Jianping Gong. (2020) Genome‐wide identification of CpG island methylator phenotype related gene signature as a novel prognostic biomarker of gastric cancer. PeerJ 8, pages e9624.
Crossref
Boris Y. Shorning, Manisha S. Dass, Matthew J. Smalley & Helen B. Pearson. (2020) The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling. International Journal of Molecular Sciences 21:12, pages 4507.
Crossref
Di QianWeichang ZhengCuixia ChenGuanghuai JingJunxuan Huang. (2020) Roles of CCNB2 and NKX3-1 in Nasopharyngeal Carcinoma . Cancer Biotherapy and Radiopharmaceuticals 35:3, pages 208-213.
Crossref
Haiying Li, Lili Wang, Zhang Li, Xu Geng, Ming Li, Qi Tang, Chunxiao Wu & Zhiming Lu. (2020) SOX2 has dual functions as a regulator in the progression of neuroendocrine prostate cancer. Laboratory Investigation 100:4, pages 570-582.
Crossref
Ranchana Yeewa, Aya Naiki-Ito, Taku Naiki, Hiroyuki Kato, Shugo Suzuki, Teera Chewonarin & Satoru Takahashi. (2020) Hexane Insoluble Fraction from Purple Rice Extract Retards Carcinogenesis and Castration-Resistant Cancer Growth of Prostate Through Suppression of Androgen Receptor Mediated Cell Proliferation and Metabolism. Nutrients 12:2, pages 558.
Crossref
Nami Takada, Haruto Nishida, Yuzo Oyama, Takahiro Kusaba, Hiroko Kadowaki, Motoki Arakane, Junpei Wada, Shogo Urabe & Tsutomu Daa. (2020) Immunohistochemical Reactivity of Prostate-Specific Markers for Salivary Duct Carcinoma. Pathobiology 87:1, pages 30-36.
Crossref
Katherine A. Giles, Cathryn M. Gould, Qian Du, Ksenia Skvortsova, Jenny Z. Song, Madhavi P. Maddugoda, Joanna Achinger-Kawecka, Clare Stirzaker, Susan J. Clark & Phillippa C. Taberlay. (2019) Integrated epigenomic analysis stratifies chromatin remodellers into distinct functional groups. Epigenetics & Chromatin 12:1.
Crossref
O. Mankovska, G. Gerashchenko, E. Rozenberg, E. Stakhovsky, O. Kononenko, Yu. Bondarenko & V. Kashuba. (2019) Analysis of Aurora kinases genes expression points on their distinct roles in prostate cancer development. The Ukrainian Biochemical Journal 91:6, pages 15-26.
Crossref
Peter Ulz, Samantha Perakis, Qing Zhou, Tina Moser, Jelena Belic, Isaac Lazzeri, Albert Wölfler, Armin Zebisch, Armin Gerger, Gunda Pristauz, Edgar Petru, Brandon White, Charles E. S. Roberts, John St. John, Michael G. Schimek, Jochen B. Geigl, Thomas Bauernhofer, Heinz Sill, Christoph Bock, Ellen Heitzer & Michael R. Speicher. (2019) Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection. Nature Communications 10:1.
Crossref
Kathleen E. Houlahan, Yu-Jia Shiah, Alexander Gusev, Jiapei Yuan, Musaddeque Ahmed, Anamay Shetty, Susmita G. Ramanand, Cindy Q. Yao, Connor Bell, Edward O’Connor, Vincent Huang, Michael Fraser, Lawrence E. Heisler, Julie Livingstone, Takafumi N. Yamaguchi, Alexandre Rouette, Adrien Foucal, Shadrielle Melijah G. Espiritu, Ankit Sinha, Michelle Sam, Lee Timms, Jeremy Johns, Ada Wong, Alex Murison, Michèle Orain, Valérie Picard, Hélène Hovington, Alain Bergeron, Louis Lacombe, Mathieu Lupien, Yves Fradet, Bernard Têtu, John D. McPherson, Bogdan Pasaniuc, Thomas Kislinger, Melvin L. K. Chua, Mark M. Pomerantz, Theodorus van der Kwast, Matthew L. Freedman, Ram S. Mani, Housheng H. He, Robert G. Bristow & Paul C. Boutros. (2019) Genome-wide germline correlates of the epigenetic landscape of prostate cancer. Nature Medicine 25:10, pages 1615-1626.
Crossref
Gaye Lightbody, Valeriia Haberland, Fiona Browne, Laura Taggart, Huiru Zheng, Eileen Parkes & Jaine K Blayney. (2019) Review of applications of high-throughput sequencing in personalized medicine: barriers and facilitators of future progress in research and clinical application. Briefings in Bioinformatics 20:5, pages 1795-1811.
Crossref
Mark P. Labrecque, Ilsa M. Coleman, Lisha G. Brown, Lawrence D. True, Lori Kollath, Bryce Lakely, Holly M. Nguyen, Yu C. Yang, Rui M. Gil da Costa, Arja Kaipainen, Roger Coleman, Celestia S. Higano, Evan Y. Yu, Heather H. Cheng, Elahe A. Mostaghel, Bruce Montgomery, Michael T. Schweizer, Andrew C. Hsieh, Daniel W. Lin, Eva Corey, Peter S. Nelson & Colm Morrissey. (2019) Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer. Journal of Clinical Investigation 129:10, pages 4492-4505.
Crossref
Jae-Seung Chung, Yugang Wang, James Henderson, Udit Singhal, Yuanyuan Qiao, Alexander B. Zaslavsky, Daniel H. Hovelson, Daniel E. Spratt, Zachery Reichert, Ganesh S. Palapattu, Russell S. Taichman, Scott A. Tomlins & Todd M. Morgan. (2019) Circulating Tumor Cell–Based Molecular Classifier for Predicting Resistance to Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer. Neoplasia 21:8, pages 802-809.
Crossref
Arman Shahabi, Behrooz Naghili, Khalil Ansarin & Nosratollah Zarghami. (2019) The relationship between microRNAs and Rab family GTPases in human cancers. Journal of Cellular Physiology 234:8, pages 12341-12352.
Crossref
Jia‑Juan HsiehMing‑Mo HouJohn ChangYung‑Chi ShenHsin‑Yi ChengTodd Hsu. (2019) RAB38 is a potential prognostic factor for tumor recurrence in non‑small cell lung cancer. Oncology Letters.
Crossref
Ken-ichi Takayama, Yutaka Suzuki, Shinichiro Yamamoto, Daisuke Obinata, Satoru Takahashi & Satoshi Inoue. (2019) Integrative Genomic Analysis of OCT1 Reveals Coordinated Regulation of Androgen Receptor in Advanced Prostate Cancer. Endocrinology 160:2, pages 463-472.
Crossref
Zhizhuo Zhang, Kern Rei Chng, Shreyas Lingadahalli, Zikai Chen, Mei Hui Liu, Huy Hoang Do, Shaojiang Cai, Nicola Rinaldi, Huay Mei Poh, Guoliang Li, Ying Ying Sung, Charlie L. Heng, Leighton J. Core, Si Kee Tan, Xiaoan Ruan, John T. Lis, Manolis Kellis, Yijun Ruan, Wing-Kin Sung & Edwin Cheung. (2019) An AR-ERG transcriptional signature defined by long-range chromatin interactomes in prostate cancer cells. Genome Research 29:2, pages 223-235.
Crossref
A. A. Budko, P. A. Khesina, L. M. Diakov & N. L. Lazarevich. (2019) Small GTPase Rab3B: biological properties and possible role in carcinogenesis. Advances in molecular oncology 5:4, pages 78-85.
Crossref
Shahrzad Rafiei, Bin Gui, Jiaxin Wu, X. Shirley Liu, Adam S. Kibel & Li Jia. (2019) Targeting the MIF/CXCR7/AKT Signaling Pathway in Castration-Resistant Prostate Cancer. Molecular Cancer Research 17:1, pages 263-276.
Crossref
Daksh Thaper, Sepideh Vahid & Amina Zoubeidi. 2019. Prostate Cancer. Prostate Cancer 437 462 .
Shuvra Shekhar Roy, Ananda Kishore Mukherjee & Shantanu Chowdhury. (2018) Insights about genome function from spatial organization of the genome. Human Genomics 12:1.
Crossref
Shreyas Lingadahalli, Sudhir Jadhao, Ying Ying Sung, Mi Chen, Lingling Hu, Xin Chen & Edwin Cheung. (2018) Novel lncRNA LINC00844 Regulates Prostate Cancer Cell Migration and Invasion through AR Signaling . Molecular Cancer Research 16:12, pages 1865-1878.
Crossref
Ken-ichi Takayama. 2018. Advances in Testosterone Action. Advances in Testosterone Action.
David P. Labbé & Myles Brown. (2018) Transcriptional Regulation in Prostate Cancer. Cold Spring Harbor Perspectives in Medicine 8:11, pages a030437.
Crossref
Tanya E. Johnson, Ji-Hoon Lee, Logan R. Myler, Yi Zhou, Trenell J. Mosley, Soo-Hyun Yang, Nadima Uprety, Jonghwan Kim & Tanya T. Paull. (2018) Homeodomain Proteins Directly Regulate ATM Kinase Activity. Cell Reports 24:6, pages 1471-1483.
Crossref
Angélique Quartier, Laure Chatrousse, Claire Redin, Céline Keime, Nicolas Haumesser, Anne Maglott-Roth, Laurent Brino, Stéphanie Le Gras, Alexandra Benchoua, Jean-Louis Mandel & Amélie Piton. (2018) Genes and Pathways Regulated by Androgens in Human Neural Cells, Potential Candidates for the Male Excess in Autism Spectrum Disorder. Biological Psychiatry 84:4, pages 239-252.
Crossref
Carlos Eduardo Fonseca-Alves, Priscila Emiko Kobayashi & Renée Laufer-Amorim. (2018) Evaluation of NKX3.1 and C-MYC expression in canine prostatic cancer. Research in Veterinary Science 118, pages 365-370.
Crossref
Lucas F. daSilva, Felipe C. Beckedorff, Ana C. Ayupe, Murilo S. Amaral, Vinícius Mesel, Alexandre Videira, Eduardo M. Reis, João C. Setubal & Sergio Verjovski-Almeida. (2018) Chromatin Landscape Distinguishes the Genomic Loci of Hundreds of Androgen-Receptor-Associated LincRNAs From the Loci of Non-associated LincRNAs. Frontiers in Genetics 9.
Crossref
Mark A White, Efrosini Tsouko, Chenchu Lin, Kimal Rajapakshe, Jeffrey M Spencer, Sandi R Wilkenfeld, Sheiva S Vakili, Thomas L Pulliam, Dominik Awad, Fotis Nikolos, Rajasekhara Reddy Katreddy, Benny Abraham Kaipparettu, Arun Sreekumar, Xiaoliu Zhang, Edwin Cheung, Cristian Coarfa & Daniel E Frigo. (2018) GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling. Endocrine-Related Cancer 25:4, pages 453-469.
Crossref
Yiqiao Huang, Xianhan Jiang, Xue Liang & Ganggang Jiang. (2018) Molecular and cellular mechanisms of castration resistant prostate cancer (Review). Oncology Letters.
Crossref
Harrison K. Tsai, Jonathan Lehrer, Mohammed Alshalalfa, Nicholas Erho, Elai Davicioni & Tamara L. Lotan. (2017) Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma. BMC Cancer 17:1.
Crossref
Ihab S. Atta. (2017) NKX3.1 versus cyclin D1 expression in prostatic adenocarcinoma. Egyptian Journal of Pathology 37:2, pages 306-314.
Crossref
Zhifei Luo, Suhn Kyong Rhie, Fides D. Lay & Peggy J. Farnham. (2017) A Prostate Cancer Risk Element Functions as a Repressive Loop that Regulates HOXA13. Cell Reports 21:6, pages 1411-1417.
Crossref
Mayuko Kanayama, Toshiya Hayano, Michinori Koebis, Tatsuya Maeda, Yoko Tabe, Shigeo Horie & Atsu Aiba. (2017) Hyperactive mTOR induces neuroendocrine differentiation in prostate cancer cell with concurrent up-regulation of IRF1. The Prostate 77:15, pages 1489-1498.
Crossref
Aditya Dutta, Sukanya Panja, Renu K. Virk, Jaime Yeji Kim, Roseann Zott, Serge Cremers, David M. Golombos, Deli Liu, Juan Miguel Mosquera, Elahe A. Mostaghel, Christopher E. Barbieri, Antonina Mitrofanova & Cory Abate-Shen. (2017) Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition. European Urology 72:4, pages 499-506.
Crossref
Sangeeta Kumari, Dhirodatta Senapati & Hannelore V Heemers. (2017) Rationale for the development of alternative forms of androgen deprivation therapy. Endocrine-Related Cancer 24:8, pages R275-R295.
Crossref
Xiaoyu Qin, Jiongyi Wang, Xinxin Wang, Feng Liu, Bin Jiang & Yanjie Zhang. (2017) Targeting Rabs as a novel therapeutic strategy for cancer therapy. Drug Discovery Today 22:8, pages 1139-1147.
Crossref
Frank Claessens, Steven Joniau & Christine Helsen. (2017) Comparing the rules of engagement of androgen and glucocorticoid receptors. Cellular and Molecular Life Sciences 74:12, pages 2217-2228.
Crossref
Flaminia Talos, Antonina Mitrofanova, Sarah K. Bergren, Andrea Califano & Michael M. Shen. (2017) A computational systems approach identifies synergistic specification genes that facilitate lineage conversion to prostate tissue. Nature Communications 8:1.
Crossref
Roxanne Toivanen & Michael M. Shen. (2017) Prostate organogenesis: tissue induction, hormonal regulation and cell type specification. Development 144:8, pages 1382-1398.
Crossref
Mengzhu Xue, Haiyue Liu, Liwen Zhang, Hongyuan Chang, Yuwei Liu, Shaowei Du, Yingqun Yang & Peng Wang. (2017) Computational identification of mutually exclusive transcriptional drivers dysregulating metastatic microRNAs in prostate cancer. Nature Communications 8:1.
Crossref
Golnaz Khakpour, Mehrdad Noruzinia, Pantea Izadi, Fatemeh Karami, Mohammad Ahmadvand, Ramin Heshmat, Mahsa M Amoli & Javad Tavakkoly-Bazzaz. (2017) Methylomics of breast cancer: Seeking epimarkers in peripheral blood of young subjects. Tumor Biology 39:3, pages 101042831769504.
Crossref
Daisuke Obinata, Kenichi Takayama, Satoru Takahashi & Satoshi Inoue. (2017) Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer. Cancers 9:12, pages 22.
Crossref
Ling Wang, Tore Skotland, Viktor Berge, Kirsten Sandvig & Alicia Llorente. (2017) Exosomal proteins as prostate cancer biomarkers in urine: From mass spectrometry discovery to immunoassay-based validation. European Journal of Pharmaceutical Sciences 98, pages 80-85.
Crossref
Ken-ichi Takayama & Satoshi Inoue. 2017. Molecular Oncology: Underlying Mechanisms and Translational Advancements. Molecular Oncology: Underlying Mechanisms and Translational Advancements 205 222 .
D Obinata, K Takayama, K Fujiwara, T Suzuki, S Tsutsumi, N Fukuda, H Nagase, T Fujimura, T Urano, Y Homma, H Aburatani, S Takahashi & S Inoue. (2016) Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth. Oncogene 35:49, pages 6350-6358.
Crossref
Collene R Jeter, Bigang Liu, Yue Lu, Hsueh-Ping Chao, Dingxiao Zhang, Xin Liu, Xin Chen, Qiuhui Li, Kiera Rycaj, Tammy Calhoun-Davis, Li Yan, Qiang Hu, Jianmin Wang, Jianjun Shen, Song Liu & Dean G Tang. (2016) NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis. Cell Discovery 2:1.
Crossref
Wenan Chen, Shannon K McDonnell, Stephen N Thibodeau, Lori S Tillmans & Daniel J Schaid. (2016) Incorporating Functional Annotations for Fine-Mapping Causal Variants in a Bayesian Framework Using Summary Statistics. Genetics 204:3, pages 933-958.
Crossref
Haiyang Guo, Musaddeque Ahmed, Fan Zhang, Cindy Q Yao, SiDe Li, Yi Liang, Junjie Hua, Fraser Soares, Yifei Sun, Jens Langstein, Yuchen Li, Christine Poon, Swneke D Bailey, Kinjal Desai, Teng Fei, Qiyuan Li, Dorota H Sendorek, Michael Fraser, John R Prensner, Trevor J Pugh, Mark Pomerantz, Robert G Bristow, Mathieu Lupien, Felix Y Feng, Paul C Boutros, Matthew L Freedman, Martin J Walsh & Housheng Hansen He. (2016) Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer. Nature Genetics 48:10, pages 1142-1150.
Crossref
Stephen Wilson, Jianfei Qi & Fabian V. Filipp. (2016) Refinement of the androgen response element based on ChIP-Seq in androgen-insensitive and androgen-responsive prostate cancer cell lines. Scientific Reports 6:1.
Crossref
Hong-Jian Jin, Segun Jung, Auditi R. DebRoy & Ramana V. Davuluri. (2016) Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer. Oncotarget 7:34, pages 54616-54626.
Crossref
Ken-ichi Takayama & Satoshi Inoue. (2016) The emerging role of noncoding RNA in prostate cancer progression and its implication on diagnosis and treatment. Briefings in Functional Genomics 15:3, pages 257-265.
Crossref
Achuth Padmanabhan, Varsha Rao, Angelo M. De Marzo & Charles J. Bieberich. (2016) Regulating NKX3.1 stability and function: Post-translational modifications and structural determinants. The Prostate 76:6, pages 523-533.
Crossref
Bing He & Kai Tan. (2016) Understanding transcriptional regulatory networks using computational models. Current Opinion in Genetics & Development 37, pages 101-108.
Crossref
Eric Metzger, Dominica Willmann, Joel McMillan, Ignasi Forne, Philipp Metzger, Stefan Gerhardt, Kerstin Petroll, Anne von Maessenhausen, Sylvia Urban, Anne-Kathrin Schott, Alexsandra Espejo, Adrien Eberlin, Daniel Wohlwend, Katrin M Schüle, Michael Schleicher, Sven Perner, Mark T Bedford, Manfred Jung, Jörn Dengjel, Ralf Flaig, Axel Imhof, Oliver Einsle & Roland Schüle. (2016) Assembly of methylated KDM1A and CHD1 drives androgen receptor–dependent transcription and translocation. Nature Structural & Molecular Biology 23:2, pages 132-139.
Crossref
Robert Liefke, Indra M. Windhof-Jaidhauser, Jochen Gaedcke, Gabriela Salinas-Riester, Feizhen Wu, Michael Ghadimi & Sebastian Dango. (2015) The oxidative demethylase ALKBH3 marks hyperactive gene promoters in human cancer cells. Genome Medicine 7:1.
Crossref
Eleanor F. Need, Luke A. Selth, Andrew P. Trotta, Damien A. Leach, Lauren Giorgio, Melissa A. O’Loughlin, Eric Smith, Peter G. Gill, Wendy V. Ingman, J. Dinny Graham & Grant Buchanan. (2015) The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype. BMC Cancer 15:1.
Crossref
Alicia M. Blessing, Sathya Ganesan, Kimal Rajapakshe, Ying Ying Sung, Lakshmi Reddy Bollu, Yan Shi, Edwin Cheung, Cristian Coarfa, Jeffrey T. Chang, Donald P. McDonnell & Daniel E. Frigo. (2015) Identification of a Novel Coregulator, SH3YL1, That Interacts With the Androgen Receptor N-Terminus. Molecular Endocrinology 29:10, pages 1426-1439.
Crossref
Ying Han, Dennis J. Hazelett, Fredrik Wiklund, Fredrick R. Schumacher, Daniel O. Stram, Sonja I. Berndt, Zhaoming Wang, Kristin A. Rand, Robert N. Hoover, Mitchell J. Machiela, Merideth Yeager, Laurie Burdette, Charles C. Chung, Amy Hutchinson, Kai Yu, Jianfeng Xu, Ruth C. Travis, Timothy J. Key, Afshan Siddiq, Federico Canzian, Atsushi Takahashi, Michiaki Kubo, Janet L. Stanford, Suzanne Kolb, Susan M. Gapstur, W. Ryan Diver, Victoria L. Stevens, Sara S. Strom, Curtis A. Pettaway, Ali Amin Al Olama, Zsofia Kote-Jarai, Rosalind A. Eeles, Edward D. Yeboah, Yao Tettey, Richard B. Biritwum, Andrew A. Adjei, Evelyn Tay, Ann Truelove, Shelley Niwa, Anand P. Chokkalingam, William B. Isaacs, Constance Chen, Sara Lindstrom, Loic Le Marchand, Edward L. Giovannucci, Mark Pomerantz, Henry Long, Fugen Li, Jing Ma, Meir Stampfer, Esther M. John, Sue A. Ingles, Rick A. Kittles, Adam B. Murphy, William J. Blot, Lisa B. Signorello, Wei Zheng, Demetrius Albanes, Jarmo Virtamo, Stephanie Weinstein, Barbara Nemesure, John Carpten, M. Cristina Leske, Suh-Yuh Wu, Anselm J. M. Hennis, Benjamin A. Rybicki, Christine Neslund-Dudas, Ann W. Hsing, Lisa Chu, Phyllis J. Goodman, Eric A. Klein, S. Lilly Zheng, John S. Witte, Graham Casey, Elio Riboli, Qiyuan Li, Matthew L. Freedman, David J. Hunter, Henrik Gronberg, Michael B. Cook, Hidewaki Nakagawa, Peter Kraft, Stephen J. Chanock, Douglas F. Easton, Brian E. Henderson, Gerhard A. Coetzee, David V. Conti & Christopher A. Haiman. (2015) Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions. Human Molecular Genetics 24:19, pages 5603-5618.
Crossref
Ali Amin Al Olama, Tokhir Dadaev, Dennis J. Hazelett, Qiuyan Li, Daniel Leongamornlert, Edward J. Saunders, Sarah Stephens, Clara Cieza-Borrella, Ian Whitmore, Sara Benlloch Garcia, Graham G. Giles, Melissa C. Southey, Liesel Fitzgerald, Henrik Gronberg, Fredrik Wiklund, Markus Aly, Brian E. Henderson, Fredrick Schumacher, Christopher A. Haiman, Johanna Schleutker, Tiina Wahlfors, Teuvo L. Tammela, Børge G. Nordestgaard, Tim J. Key, Ruth C. Travis, David E. Neal, Jenny L. Donovan, Freddie C. Hamdy, Paul Pharoah, Nora Pashayan, Kay-Tee Khaw, Janet L. Stanford, Stephen N. Thibodeau, Shannon K. Mcdonnell, Daniel J. Schaid, Christiane Maier, Walther Vogel, Manuel Luedeke, Kathleen Herkommer, Adam S. Kibel, Cezary Cybulski, Dominika Wokołorczyk, Wojciech Kluzniak, Lisa Cannon-Albright, Hermann Brenner, Katja Butterbach, Volker Arndt, Jong Y. Park, Thomas Sellers, Hui-Yi Lin, Chavdar Slavov, Radka Kaneva, Vanio Mitev, Jyotsna Batra, Judith A. Clements, Amanda Spurdle, Manuel R. Teixeira, Paula Paulo, Sofia Maia, Hardev Pandha, Agnieszka Michael, Andrzej Kierzek, Koveela Govindasami, Michelle Guy, Artitaya Lophatonanon, Kenneth Muir, Ana Viñuela, Andrew A. Brown, Mathew Freedman, David V. Conti, Douglas Easton, Gerhard A. Coetzee, Rosalind A. Eeles & Zsofia Kote-Jarai. (2015) Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans. Human Molecular Genetics 24:19, pages 5589-5602.
Crossref
Ken-ichi Takayama, Aya Misawa, Takashi Suzuki, Kiyoshi Takagi, Yoshihide Hayashizaki, Tetsuya Fujimura, Yukio Homma, Satoru Takahashi, Tomohiko Urano & Satoshi Inoue. (2015) TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression. Nature Communications 6:1.
Crossref
Haitao Chen, Hongjie Yu, Jianqing Wang, Zheng Zhang, Zhengrong Gao, Zhuo Chen, Yulan Lu, Wennuan Liu, Deke Jiang, S.Lilly Zheng, Gong-hong Wei, William B. Issacs, Junjie Feng & Jianfeng Xu. (2015) Systematic enrichment analysis of potentially functional regions for 103 prostate cancer risk-associated loci. The Prostate 75:12, pages 1264-1276.
Crossref
Wenhuan Guo, Anne L. Keener, Yifeng Jing, Liquan Cai, Junkui Ai, Jian Zhang, Guohui Fu & Zhou Wang. (2015) FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells. The Prostate 75:9, pages 976-987.
Crossref
Jian Yang, Wei Liu, Xin’an Lu, Yan Fu, Lin Li & Yongzhang Luo. (2015) High expression of small GTPase Rab3D promotes cancer progression and metastasis. Oncotarget 6:13, pages 11125-11138.
Crossref
Kouhei Sakurai, Brian J. Reon, Jordan Anaya & Anindya Dutta. (2015) The lncRNA DRAIC / PCAT29 Locus Constitutes a Tumor-Suppressive Nexus . Molecular Cancer Research 13:5, pages 828-838.
Crossref
Ken-ichi Takayama, Takashi Suzuki, Shuichi Tsutsumi, Tetsuya Fujimura, Tomohiko Urano, Satoru Takahashi, Yukio Homma, Hiroyuki Aburatani & Satoshi Inoue. (2014) RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer. Oncotarget 6:4, pages 2263-2276.
Crossref
Ali Naderi. (2015) Coagulation factor VII is regulated by androgen receptor in breast cancer. Experimental Cell Research 331:1, pages 239-250.
Crossref
Sarah K. Sasse & Anthony N. Gerber. (2015) Feed-forward transcriptional programming by nuclear receptors: Regulatory principles and therapeutic implications. Pharmacology & Therapeutics 145, pages 85-91.
Crossref
Janusz Puc, Piotr Kozbial, Wenbo Li, Yuliang Tan, Zhijie Liu, Tom Suter, Kenneth A. Ohgi, Jie Zhang, Aneel K. Aggarwal & Michael G. Rosenfeld. (2015) Ligand-Dependent Enhancer Activation Regulated by Topoisomerase-I Activity. Cell 160:3, pages 367-380.
Crossref
Ken-ichi Takayama & Satoshi Inoue. 2015. Long Noncoding RNAs. Long Noncoding RNAs 191 210 .
Ken-ichi TakayamaTakashi SuzukiShuichi TsutsumiTetsuya FujimuraSatoru TakahashiYukio HommaTomohiko UranoHiroyuki AburataniSatoshi Inoue. (2014) Integrative Analysis of FOXP1 Function Reveals a Tumor-Suppressive Effect in Prostate Cancer. Molecular Endocrinology 28:12, pages 2012-2024.
Crossref
Feng Ye, Hailin Tang, Qing Liu, Xinhua Xie, Minqing Wu, Xiaoping Liu, Bo Chen & Xiaoming Xie. (2014) miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family. Journal of Translational Medicine 12:1.
Crossref
Rajesh Thangapazham, Francisco Saenz, Shilpa Katta, Ahmed A Mohamed, Shyh-Han Tan, Gyorgy Petrovics, Shiv Srivastava & Albert Dobi. (2014) Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer. BMC Cancer 14:1.
Crossref
Ali Amin Al Olama, Zsofia Kote-Jarai, Sonja I Berndt, David V Conti, Fredrick Schumacher, Ying Han, Sara Benlloch, Dennis J Hazelett, Zhaoming Wang, Ed Saunders, Daniel Leongamornlert, Sara Lindstrom, Sara Jugurnauth-Little, Tokhir Dadaev, Malgorzata Tymrakiewicz, Daniel O Stram, Kristin Rand, Peggy Wan, Alex Stram, Xin Sheng, Loreall C Pooler, Karen Park, Lucy Xia, Jonathan Tyrer, Laurence N Kolonel, Loic Le Marchand, Robert N Hoover, Mitchell J Machiela, Merideth Yeager, Laurie Burdette, Charles C Chung, Amy Hutchinson, Kai Yu, Chee Goh, Mahbubl Ahmed, Koveela Govindasami, Michelle Guy, Teuvo L J Tammela, Anssi Auvinen, Tiina Wahlfors, Johanna Schleutker, Tapio Visakorpi, Katri A Leinonen, Jianfeng Xu, Markus Aly, Jenny Donovan, Ruth C Travis, Tim J Key, Afshan Siddiq, Federico Canzian, Kay-Tee Khaw, Atsushi Takahashi, Michiaki Kubo, Paul Pharoah, Nora Pashayan, Maren Weischer, Borge G Nordestgaard, Sune F Nielsen, Peter Klarskov, Martin Andreas Røder, Peter Iversen, Stephen N Thibodeau, Shannon K McDonnell, Daniel J Schaid, Janet L Stanford, Suzanne Kolb, Sarah Holt, Beatrice Knudsen, Antonio Hurtado Coll, Susan M Gapstur, W Ryan Diver, Victoria L Stevens, Christiane Maier, Manuel Luedeke, Kathleen Herkommer, Antje E Rinckleb, Sara S Strom, Curtis Pettaway, Edward D Yeboah, Yao Tettey, Richard B Biritwum, Andrew A Adjei, Evelyn Tay, Ann Truelove, Shelley Niwa, Anand P Chokkalingam, Lisa Cannon-Albright, Cezary Cybulski, Dominika Wokołorczyk, Wojciech Kluźniak, Jong Park, Thomas Sellers, Hui-Yi Lin, William B Isaacs, Alan W Partin, Hermann Brenner, Aida Karina Dieffenbach, Christa Stegmaier, Constance Chen, Edward L Giovannucci, Jing Ma, Meir Stampfer, Kathryn L Penney, Lorelei Mucci, Esther M John, Sue A Ingles, Rick A Kittles, Adam B Murphy, Hardev Pandha, Agnieszka Michael, Andrzej M Kierzek, William Blot, Lisa B Signorello, Wei Zheng, Demetrius Albanes, Jarmo Virtamo, Stephanie Weinstein, Barbara Nemesure, John Carpten, Cristina Leske, Suh-Yuh Wu, Anselm Hennis, Adam S Kibel, Benjamin A Rybicki, Christine Neslund-Dudas, Ann W Hsing, Lisa Chu, Phyllis J Goodman, Eric A Klein, S Lilly Zheng, Jyotsna Batra, Judith Clements, Amanda Spurdle, Manuel R Teixeira, Paula Paulo, Sofia Maia, Chavdar Slavov, Radka Kaneva, Vanio Mitev, John S Witte, Graham Casey, Elizabeth M Gillanders, Daniella Seminara, Elio Riboli, Freddie C Hamdy, Gerhard A Coetzee, Qiyuan Li, Matthew L Freedman, David J Hunter, Kenneth Muir, Henrik Gronberg, David E Neal, Melissa Southey, Graham G Giles, Gianluca Severi, Michael B Cook, Hidewaki Nakagawa, Fredrik Wiklund, Peter Kraft, Stephen J Chanock, Brian E Henderson, Douglas F Easton, Rosalind A Eeles & Christopher A Haiman. (2014) A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nature Genetics 46:10, pages 1103-1109.
Crossref
Emma Shtivelman, Tomasz M. Beer & Christopher P. Evans. (2014) Molecular pathways and targets in prostate cancer. Oncotarget 5:17, pages 7217-7259.
Crossref
Rebecca J Asch-Kendrick, Mark A Samols, Mohammed T Lilo, Andrea P Subhawong, Rajni Sharma, Peter B Illei, Pedram Argani & Ashley Cimino-Mathews. (2014) NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas. Journal of Clinical Pathology 67:9, pages 768-771.
Crossref
Akiko Omori, Shinichi Miyagawa, Yukiko Ogino, Masayo Harada, Kenichiro Ishii, Yoshiki Sugimura, Hajime Ogino, Naomi Nakagata & Gen Yamada. (2014) Essential Roles of Epithelial Bone Morphogenetic Protein Signaling During Prostatic Development. Endocrinology 155:7, pages 2534-2544.
Crossref
Magdalena M. Grabowska, Amicia D. Elliott, David J. DeGraff, Philip D. Anderson, Govindaraj Anumanthan, Hironobu Yamashita, Qian Sun, David B. Friedman, David L. Hachey, Xiuping Yu, Jonathan H. Sheehan, Jung-Mo Ahn, Ganesh V. Raj, David W. Piston, Richard M. Gronostajski & Robert J. Matusik. (2014) NFI Transcription Factors Interact with FOXA1 to Regulate Prostate-Specific Gene Expression. Molecular Endocrinology 28:6, pages 949-964.
Crossref
Gillian H. Little, Sanjeev K. Baniwal, Helty Adisetiyo, Susan Groshen, Nyam-Osor Chimge, Sun Young Kim, Omar Khalid, Debra Hawes, Jeremy O. Jones, Jacek Pinski, Dustin E. Schones & Baruch Frenkel. (2014) Differential Effects of RUNX2 on the Androgen Receptor in Prostate Cancer: Synergistic Stimulation of a Gene Set Exemplified by SNAI2 and Subsequent Invasiveness. Cancer Research 74:10, pages 2857-2868.
Crossref
Khin Moh Moh Aung, Siu Yee New, Shuzhen Hong, Laura Sutarlie, Michelle Gek Liang Lim, Si Kee Tan, Edwin Cheung & Xiaodi Su. (2014) Studying forkhead box protein A1–DNA interaction and ligand inhibition using gold nanoparticles, electrophoretic mobility shift assay, and fluorescence anisotropy. Analytical Biochemistry 448, pages 95-104.
Crossref
Georgi K Marinov, Anshul Kundaje, Peter J Park & Barbara J Wold. (2014) Large-Scale Quality Analysis of Published ChIP-seq Data. G3 Genes|Genomes|Genetics 4:2, pages 209-223.
Crossref
Ying Ying Sung & Edwin Cheung. (2014) Androgen receptor co-regulatory networks in castration-resistant prostate cancer. Endocrine-Related Cancer 21:1, pages R1-R11.
Crossref
Chih-Cheng Yang, Alicia Chung, Chia-Yu Ku, Laurence M. Brill, Roy Williams & Dieter A. Wolf. (2014) Systems analysis of the prostate tumor suppressor NKX3.1 supports roles in DNA repair and luminal cell differentiation. F1000Research 3, pages 115.
Crossref
Siu Chiu Chan & Scott M. Dehm. 2014. Pharmacology & Therapeutics of Constitutively Active Receptors. Pharmacology & Therapeutics of Constitutively Active Receptors 327 366 .
Fulai Jin, Yan Li, Jesse R. Dixon, Siddarth Selvaraj, Zhen Ye, Ah Young Lee, Chia-An Yen, Anthony D. Schmitt, Celso A. Espinoza & Bing Ren. (2013) A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature 503:7475, pages 290-294.
Crossref
Kern Rei Chng & Edwin Cheung. (2013) Sequencing the transcriptional network of androgen receptor in prostate cancer. Cancer Letters 340:2, pages 254-260.
Crossref
Ken-ichi Takayama & Satoshi Inoue. (2013) Transcriptional network of androgen receptor in prostate cancer progression. International Journal of Urology 20:8, pages 756-768.
Crossref
Cai Bowen, Jeong-Ho Ju, Ji-Hoon Lee, Tanya T. Paull & Edward P. Gelmann. (2013) Functional Activation of ATM by the Prostate Cancer Suppressor NKX3.1. Cell Reports 4:3, pages 516-529.
Crossref
Mugdha Patki, Venkatesh Chari, Suneethi Sivakumaran, Mesfin Gonit, Robert Trumbly & Manohar Ratnam. (2013) The ETS Domain Transcription Factor ELK1 Directs a Critical Component of Growth Signaling by the Androgen Receptor in Prostate Cancer Cells. Journal of Biological Chemistry 288:16, pages 11047-11065.
Crossref
Paul W. Harms, Rajiv M. Patel, Monique E. Verhaegen, Thomas J. Giordano, Kevin T. Nash, Craig N. Johnson, Stephanie Daignault, Dafydd G. Thomas, Johann E. Gudjonsson, James T. Elder, Andrzej A. Dlugosz, Timothy M. Johnson, Douglas R. Fullen & Christopher K. Bichakjian. (2013) Distinct Gene Expression Profiles of Viral- and Nonviral-Associated Merkel Cell Carcinoma Revealed by Transcriptome Analysis. Journal of Investigative Dermatology 133:4, pages 936-945.
Crossref
Biswajyoti Sahu, Marko Laakso, Päivi Pihlajamaa, Kristian Ovaska, Ievgenii Sinielnikov, Sampsa Hautaniemi & Olli A. Jänne. (2013) FoxA1 Specifies Unique Androgen and Glucocorticoid Receptor Binding Events in Prostate Cancer Cells. Cancer Research 73:5, pages 1570-1580.
Crossref
Jiajia Chen, Daqing Zhang, Wenying Yan, Dongrong Yang & Bairong Shen. (2013) Translational Bioinformatics for Diagnostic and Prognostic Prediction of Prostate Cancer in the Next-Generation Sequencing Era. BioMed Research International 2013, pages 1-13.
Crossref
Frank Claessens, Liesbeth Clinckemalie, Helsen Christine, Lien Spans, Vanessa Dubois, Michaël Laurent, Steven Boonen & Dirk Vanderschueren. 2013. Androgen-Responsive Genes in Prostate Cancer. Androgen-Responsive Genes in Prostate Cancer 13 27 .
Diana A. Stavreva, Anuja A. George, Paul Klausmeyer, Lyuba Varticovski, Daniel Sack, Ty C. Voss, R. Louis Schiltz, Vicki S. Blazer, Luke R. Iwanowicz & Gordon L. Hager. (2012) Prevalent Glucocorticoid and Androgen Activity in US Water Sources. Scientific Reports 2:1.
Crossref
Chiara RecchiMiguel C. Seabra. (2012) Novel functions for Rab GTPases in multiple aspects of tumour progression. Biochemical Society Transactions 40:6, pages 1398-1403.
Crossref
José M. Matés, Juan A. Segura, Francisco J. Alonso & Javier Márquez. (2012) Oxidative stress in apoptosis and cancer: an update. Archives of Toxicology 86:11, pages 1649-1665.
Crossref
Aritro Sen, Ismary De Castro, Donald B. DeFranco, Fang-Ming Deng, Jonathan Melamed, Payel Kapur, Ganesh V. Raj, Randall Rossi & Stephen R. Hammes. (2012) Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation. Journal of Clinical Investigation 122:7, pages 2469-2481.
Crossref
Patrick McCoy, Stefano Mangiola, Geoff Macintyre, Ryan Hutchinson, Ben Tran, Matthew KH Hong, Natalie Kurganovs, Michael J. Clarkson, Marek Cmero, Michael Kerger, Ryan Stuchbery, Ken Chow, Izhak Haviv, Andrew Ryan, Anthony J. Costello, Niall M. Corcoran & Christopher M. Hovens. (2018) MSH2 is Inactivated by Multiple Mechanisms in Prostate Tumors, Leading to a Distinct Immune Response and Clinical Outcome Compared to MSH2 Deficient Colorectal Cancer. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.